“Boston Scientific Beats Earnings Expectations in Q1 2023 and Projects Strong Future Growth”

Investing.com – Boston Scientific (NYSE: BSX ) posted first-quarter EPS of $0.47, $0.04 better than expected, compared to $0.43 EPS. Revenue for the quarter came in at $3.39B, versus a forecast of $3.16B.

h2 Projections:/h2

Boston Scientific expects EPS of $0.48-$0.50 in the second quarter of fiscal 2023, versus a consensus forecast of $0.48.

Boston Scientific expects FY2023 EPS of $1.90-$1.96, versus a consensus forecast of $1.91.

Boston Scientific shares closed at $51.11, which represents an increase of 11.33% in the last three months and an increase of 18.69% in the last 12 months.

Boston Scientific has received 1 positive reviews and 10 negative reviews for its BPA in the last 90 days. Learn how Boston Scientific’s stock reacted to the company’s results here.

According to good performance.

Find out recent results from Boston Scientific as well as company financials here.

Stay up to date with all the company figures by visiting our Results Calendar.